Skip to main content

Moderna Price Target Raised To $234 From $208 At Piper Sandler

Piper Sandler analyst Edward Tenthoff raised the firm's price target on Moderna to $234 from $208 and reiterates an Overweight rating on the shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.